Home › Calculator › TLPPF Dividend Calculator 2026
TLPPF Dividend DRIP Calculator 2026
19.05% YieldHealthcareTelix Pharmaceuticals Limited · OTC
Price: $10.50 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When TLPPF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your TLPPF snowball 📈
$10,000 in TLPPF → $12.32M in 10 years · $190.87/month
About Telix Pharmaceuticals Limited (TLPPF) — Dividend Analysis 2026
Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and Gozellix for the treatment of prostate cancer. The company is also developing TLX592, a prostate cancer therapy candidate for targeted alpha therapy based on its proprietary RADmAb-engineered antibody technology; TLX252 for the treatment of patients with advanced metastatic kidney cancer; TLX400, a bladder fibroblast activation protein for treating various tumors; TLX102, a large amino acid transporter-targeting small molecule-based alpha therapy candidate for the treatment of glioblastoma and multiple myeloma; TLX300 for treating soft tissue sarcoma; and TLX090, a bone-seeking agent for bone metastases and pain palliation. In addition, it is developing BiPASS, which is in Phase 3 clinical trial for prostate cancer diagnosis; AlFluor, a novel PET radiochemistry solution; TLX250-Px, a PET diagnostic imaging agent; and TLX101-Px, a radiolabeled amino acid PET agent. It operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company has strategic collaboration with University Hospital Essen. The company was founded in 2015 and is headquartered in North Melbourne, Australia.
Compare TLPPF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full TLPPF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TLPPF position with:
🌍 TLPPF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold TLPPF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 19.05% | 16.25% | $1,905 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 16.19% | 13.39% | $1,619 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 15.24% | 12.44% | $1,524 / yr |
| 🇬🇧 UK ISA | 0% | 19.05% | 16.25% | $1,905 / yr |
| 🇬🇧 UK Taxable | 8.75% | 17.38% | 14.58% | $1,738 / yr |
| 🇨🇦 TFSA | 0% | 19.05% | 16.25% | $1,905 / yr |
| 🇨🇦 CA Taxable | 25% | 14.29% | 11.49% | $1,429 / yr |
| 🇦🇺 Super (pension) | 15% | 16.19% | 13.39% | $1,619 / yr |
| 🇦🇺 AU Taxable | 30% | 13.33% | 10.54% | $1,334 / yr |
| 🇩🇪 DE Taxable | 26.375% | 14.03% | 11.23% | $1,403 / yr |
| 🇫🇷 FR Taxable | 30% | 13.33% | 10.54% | $1,334 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 TLPPF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 TLPPF Dividend Payment Schedule
TLPPF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 TLPPF vs Healthcare Benchmarks
How TLPPF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TLPPF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ TLPPF Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where TLPPF earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TLPPF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Telix Pharmaceuticals Limited (TLPPF) is currently trading at $10.50, 42% below its 52-week high. The current dividend yield is 19.05% based on an annual payout of $2.00 per share.
TLPPF (Telix Pharmaceuticals Limited) — 19.05% Dividend Yield Analysis
Telix Pharmaceuticals Limited (TLPPF) is a healthcare stock currently trading at $10.50 with a dividend yield of 19.05%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (19.05%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.